News about Global Pharma

Myricx Bio Secures EUR 90 Million in Series A Financing

Myricx Bio has raised EUR 90 Million (USD 114 Million) in the latest Series A financing round.

Global Pharma | 08/07/2024 | By Aishwarya |  496

SmartCella Receives EUR 50 Million to Boost Commercialization of mRNA Operations

SmartCella Holding has announced a new share issue raising approximately EUR 50 million to accelerate growth and support commercialization of the Extroducer and the company's cell and mRNA operations.

Global Pharma | 08/07/2024 | By Aishwarya |  496

Ascentage Pharma Olverembatinib Gets Approval from ISAF for Commercialization in Macau China

Ascentage Pharma has announced that its BCR-ABL1 tyrosine kinase inhibitor (TKI), olverembatinib, has been approved by the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region (SAR) of the People's Republic of China.

Global Pharma | 08/07/2024 | By Aishwarya |  387

Innovent Signs Agreement with IASO Bio for Cell Therapy

Innovent Biologics, Inc. and IASO Biotechnology have signed an agreement on a series of cooperation, including IASO Bio's purchase from Innovent regarding its relevant right of FUCASO (Equecabtagene Autoleucel) and obtaining license from Innovent regarding the intellectual property related to FUCASO, as well as Innovent's equity investment in IASO Bio.

Global Pharma | 06/07/2024 | By Aishwarya |  724

Zydus Gets Tentative Approval from USFDA for Azilsartan Medoxomil Tablets

Zydus Lifesciences Ltd. has secured a tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil Tablets, 40 mg and 80 mg (USRLD: Edarbi tablets).

Global Pharma | 06/07/2024 | By Aishwarya |  515

AbbVie Announces New Chief Executive Officer

AbbVie has announced that Robert A. Michael has assumed the role of chief executive officer (CEO) and has joined AbbVie's Board of Directors.

Global Pharma | 06/07/2024 | By Aishwarya |  1007

Zydus and Dr. Reddy to Co-Market Pertuzumab Biosimilar in India

Zydus Lifesciences and Dr. Reddy’s Laboratories Ltd. have announced the execution of a licensing agreement to co-market Pertuzumab biosimilar in India.

Global Pharma | 05/07/2024 | By Aishwarya |  1935

EMA Approves Marketing Authorization Application of Nidlegy

Philogen and Sun Pharmaceutical Industries Ltd. have announced that the European Medicines Agency (EMA) validated the submission of the Marketing Authorization Application (MAA) for Nidlegy.

Global Pharma | 05/07/2024 | By Aishwarya |  469

Quest Diagnostics Plans to Acquire LifeLabs from OMERS

Quest Diagnostics has signed a definitive agreement with OMERS to acquire LifeLabs, a trusted provider of community laboratory tests for millions of Canadians, for a value of approximately CAD 1.35 billion (approximately USD 985 million), including net debt.

Global Pharma | 04/07/2024 | By Aishwarya |  671

EMA Approves Dupixent as First-Ever Targeted Therapy for Patients with COPD

The European Medicines Agency (EMA) has recently announced their approval for Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils.

Global Pharma | 04/07/2024 | By Aishwarya |  578